H Rogge
Overview
Explore the profile of H Rogge including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rogge H, Artelt N, Endlich N, Endlich K
J Microsc
. 2017 Aug;
268(2):129-140.
PMID: 28806482
The actin cytoskeleton is a main component of cells and it is crucially involved in many physiological processes, e.g. cell motility. Changes in the actin organization can be effected by...
2.
Dykstra K, Rogge H, Stone A, Loewy J, Keith Jr J, Schwertschlag U
J Clin Pharmacol
. 2000 Aug;
40(8):880-8.
PMID: 10934673
Recombinant human interleukin-11 (rhIL-11), or Neumega rhIL-11 Growth Factor, is a recombinant cytokine that stimulates megakaryocytopoiesis, increases platelet production, and also has shown anti-inflammatory and immune-modulating activity. Mild, reversible anemia...
3.
Sands B, Bank S, Sninsky C, Robinson M, Katz S, SINGLETON J, et al.
Gastroenterology
. 1999 Jun;
117(1):58-64.
PMID: 10381910
Background & Aims: Recombinant human interleukin 11 (rhIL-11) is a cytokine with thrombocytopoietic activity and anti-inflammatory and mucosal protective effects. The objectives of this study were to investigate the safety...
4.
Rogge H
Z Lymphol
. 1993 Dec;
17(2):54-7.
PMID: 8147089
Lymph flux disturbance lead to social changes in the life of the patient. In crafts and administration there are numerous occupations which interfere with the pathophysiological conditions of the lymphedema...
5.
Rogge H
Z Lymphol
. 1993 Dec;
17(2):30-5.
PMID: 7511859
Malignant diseases and the resulting disorders may lead to the prescription of physical therapy. In addition, cancer patients may suffer from orthopaedic diseases which are treated by physical therapy, e.g....
6.
Rogge H
Z Lymphol
. 1993 Aug;
17(1):12-4.
PMID: 8379247
Two case reports are presented. A ten year-old boy is impeded in his social activities as sports and a seventeen year-old girl in uptaking the normal activities of a young...
7.
Barth K, Nielsen G, Haver B, Havik O, Molstad E, Rogge H, et al.
Psychother Psychosom
. 1988 Jan;
50(3):141-50.
PMID: 3267825
Change was assessed in 34 patients at the end of short-term dynamic psychotherapy (STDP), and at 2 follow-ups (1 year and 2 years subsequent to treatment). The assessment was made...
8.
Nielsen G, Barth K, Haver B, Havik O, Molstad E, Rogge H, et al.
Psychother Psychosom
. 1988 Jan;
50(1):35-41.
PMID: 3244829
Ten outpatients who complained of physical symptoms, without organic pathology, were treated with brief dynamic psychotherapy. Outcome ratings were provided by independent assessors at the end of therapy and 2...
9.
Barth K, Nielsen G, Havik O, Haver B, Molstad E, Rogge H, et al.
Psychother Psychosom
. 1988 Jan;
49(3-4):153-9.
PMID: 3237966
Forty-four patients were assessed for three different short-term dynamic therapies, with an evaluation form based on Sifneos' criteria for Short-Term Anxiety-Provoking Psychotherapy (STAPP). Ten patients were ascribed to STAPP, 22...
10.
Barth K, Havik O, Nielsen G, Haver B, Molstad E, Rogge H, et al.
Psychother Psychosom
. 1988 Jan;
49(1):47-52.
PMID: 3237962
The selection criteria of Sifneos' short-term anxiety-provoking psychotherapy has been assumed to consist of two separate dimensions, resources and motivation. A factor analysis revealed three factors: ego-resources, motivation for psychotherapy...